{
  "source": "Epilepsy Medication Safety Database",
  "description": "Comprehensive safety information for epilepsy medications during pregnancy",
  "extracted_at": "2025-10-05 16:23:21",
  "medications": [
    {
      "medication": "Lamotrigine",
      "brand_names": [
        "Lamictal"
      ],
      "pregnancy_category": "Category C",
      "safety_profile": "Generally considered safer during pregnancy",
      "key_points": [
        "Lower risk of major congenital malformations compared to valproate",
        "May require dose adjustments during pregnancy",
        "Therapeutic drug monitoring recommended",
        "Considered safe for breastfeeding"
      ],
      "monitoring": [
        "Regular blood level monitoring",
        "Folic acid supplementation (5mg daily)",
        "Detailed anomaly scan at 18-20 weeks"
      ]
    },
    {
      "medication": "Levetiracetam",
      "brand_names": [
        "Keppra"
      ],
      "pregnancy_category": "Category C",
      "safety_profile": "Generally considered safer during pregnancy",
      "key_points": [
        "Lower risk of major congenital malformations",
        "Good seizure control during pregnancy",
        "May require dose adjustments",
        "Considered safe for breastfeeding"
      ],
      "monitoring": [
        "Regular blood level monitoring",
        "Folic acid supplementation (5mg daily)",
        "Detailed anomaly scan at 18-20 weeks"
      ]
    },
    {
      "medication": "Valproic Acid",
      "brand_names": [
        "Depakote",
        "Depakene"
      ],
      "pregnancy_category": "Category D",
      "safety_profile": "Higher risk during pregnancy",
      "key_points": [
        "Highest risk of major congenital malformations (10-11%)",
        "Increased risk of neurodevelopmental problems",
        "Should be avoided if possible during pregnancy",
        "If necessary, use lowest effective dose"
      ],
      "monitoring": [
        "High-dose folic acid supplementation (5mg daily)",
        "Detailed anomaly scan at 18-20 weeks",
        "Consider alternative medications if possible",
        "Close monitoring for birth defects"
      ]
    },
    {
      "medication": "Carbamazepine",
      "brand_names": [
        "Tegretol"
      ],
      "pregnancy_category": "Category D",
      "safety_profile": "Moderate risk during pregnancy",
      "key_points": [
        "Risk of neural tube defects",
        "May cause vitamin K deficiency in newborn",
        "Requires folic acid supplementation",
        "Consider vitamin K supplementation in last month"
      ],
      "monitoring": [
        "Folic acid supplementation (5mg daily)",
        "Detailed anomaly scan at 18-20 weeks",
        "Vitamin K supplementation in last month",
        "Monitor for neural tube defects"
      ]
    },
    {
      "medication": "Phenytoin",
      "brand_names": [
        "Dilantin"
      ],
      "pregnancy_category": "Category D",
      "safety_profile": "Moderate risk during pregnancy",
      "key_points": [
        "Risk of fetal hydantoin syndrome",
        "May cause vitamin K deficiency",
        "Requires careful monitoring",
        "Consider alternative medications"
      ],
      "monitoring": [
        "Folic acid supplementation (5mg daily)",
        "Detailed anomaly scan at 18-20 weeks",
        "Vitamin K supplementation in last month",
        "Monitor for fetal hydantoin syndrome"
      ]
    }
  ],
  "general_guidelines": [
    "Pre-pregnancy counseling is essential",
    "Folic acid supplementation (5mg daily) before conception",
    "Regular monitoring of medication levels",
    "Multidisciplinary team approach",
    "Consider medication changes before pregnancy if possible"
  ]
}